Related by context. Frequent words. (Click for all words.) 65 placebo p = 64 symptom severity 64 Secondary endpoints included 63 achieved statistical significance 63 Secondary endpoints include 63 ACR# [002] 62 PANSS 61 placebo p 61 mg BID 60 Secondary endpoints 60 plus methotrexate 60 P = .# 60 DAS# [002] 60 dyspnea 60 mg QD 59 RLS symptoms 59 nasopharyngitis 59 Global Impression 59 cytogenetic response 59 confidence interval CI 59 hypomagnesemia 58 annualized relapse 58 ADAS cog 58 IBS symptoms 58 CI #.#-#.# [002] 58 peripheral edema 57 febrile neutropenia 57 secondary endpoint 57 GERD symptoms 57 HRQoL 57 arthralgia 57 nonresponders 57 composite endpoint 56 demonstrated statistically significant 56 plus dexamethasone 56 certolizumab pegol 56 pruritus 56 BPH symptoms 56 musculoskeletal pain 56 Disease Activity 56 vasomotor symptoms 56 leukopenia 56 asthenia 56 oral corticosteroids 56 % CI #.#-#.# [006] 56 dysmenorrhea 56 lymphopenia 56 laboratory abnormalities 56 COPD exacerbations 56 mg dose 56 discontinuations due 56 tolvaptan 55 ARICEPT 55 pramipexole 55 events AEs 55 diabetic neuropathic pain 55 ≥ 55 mucositis 55 mcg kg 55 lacosamide 55 subscales 55 systemic embolism 55 hypokalemia 55 nocturia 55 eszopiclone 55 etanercept 55 urge incontinence 55 myalgia 55 p = #.# [004] 55 LVEF 55 airflow obstruction 55 plus prednisone 55 FOLFIRI 55 treatment emergent adverse 55 XIENCE V vs. 55 orthostatic hypotension 55 6R BH4 55 erythema 55 secondary efficacy endpoints 54 placebo 54 pregabalin 54 confidence interval #.#-#.# 54 QTc 54 hypercalcemia 54 adalimumab 54 primary efficacy endpoint 54 QoL 54 stomatitis 54 TNF antagonists 54 inflammatory lesions 54 #mg dose [003] 54 LEXIVA 54 plus ribavirin 54 virologic response 54 symptomatology 54 methotrexate MTX 54 intermittent claudication 54 levetiracetam 54 LUTS 54 Postoperative 54 thromboembolic events